FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / News / Read News

Print

Maranon Capital Provides Financing for Acquisition of Ameda

January 14, 2013, 07:47 AM

Maranon Capital provided senior and mezzanine debt to support Crimson Investment’s purchase of Ameda, Inc. from Evenflo Company. Maranon also invested equity in the transaction alongside Crimson.

With a company history that spans over 70 years, Ameda is a leading provider of hospital-grade and high-end personal breast pumps, milk collection kits and accessories. Ameda’s products are used in healthcare facilities and sold through retailers in more than 40 countries globally.

“We were attracted to the opportunity by Ameda’s superior technology and brand recognition, its large installed base within healthcare facilities, and the company’s excellent retail partnerships,” remarked Greg Long, Managing Director of Maranon Capital and the lead partner for the investment. Long continued, “In addition to an attractive business model which generates recurring revenue through the sale of accessories, Ameda’s market opportunity is growing quickly in the U.S., Europe, and developing countries.”

Tom Gregory, managing director and co-founder of Maranon Capital, added “Ameda is Maranon’s second investment in partnership with Crimson since June 2012. We are pleased when Maranon’s reputation as a reliable and trusted partner is affirmed through repeat selection as the financing source for a transaction.”

Other Maranon Capital team members involved in the Ameda investment included Laura Albrecht, Principal, and Colin McCarthy, Associate. Proskauer Rose LLP provided legal counsel for Maranon.

Maranon Capital, L.P. provides senior financing, mezzanine debt and equity co-investments for private equity-backed and non-sponsored middle market transactions.

Crimson Investment is an international private equity firm. The firm concentrates on helping well positioned middle market companies reach their full global potential.

 











Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.